{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:43:24Z","timestamp":1784270604738,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.diagmicrobio.2022.115676","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T21:29:17Z","timestamp":1647379757000},"page":"115676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of a rapid neutralization assay for the detection of neutralizing antibodies against coxsackievirus B1"],"prefix":"10.1016","volume":"103","author":[{"given":"Yuanyuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfa","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongzi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5937\/pomc17-25015","article-title":"Clinical course of coxsackievirus B (1-6) infection","volume":"17","author":"Pavi\u0107","year":"2020","journal-title":"PONS - Medicinski Casopis"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0002","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/adc.64.3.404","article-title":"Chronic neonatal coxsackie myocarditis","volume":"64","author":"Goren","year":"1989","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0003","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nri.2017.148","article-title":"Passive immunotherapy of viral infections: 'super-antibodies' enter the fray","volume":"18","author":"Walker","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jmv.23359","article-title":"Molecular characteristics of human coxsackievirus B1 infection in Korea, 2008-2009","volume":"85","author":"Kim","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129272","article-title":"Transmission and demographic dynamics of coxsackievirus B1","volume":"10","author":"Chu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0006","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2337\/db13-0620","article-title":"Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes","volume":"63","author":"Oikarinen","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0007","doi-asserted-by":"crossref","first-page":"515","DOI":"10.15585\/mmwr.mm6718a2","article-title":"Enterovirus and parechovirus surveillance - United States, 2014-2016","volume":"67","author":"Abedi","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0008","doi-asserted-by":"crossref","first-page":"940","DOI":"10.15585\/mmwr.mm6434a3","article-title":"Enterovirus and human parechovirus surveillance - United States, 2009-2013","volume":"64","author":"Abedi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0009","first-page":"1577","article-title":"Nonpolio enterovirus and human parechovirus surveillance \u2014 United States, 2006-2008","volume":"59","author":"Villarruel","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0010","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2337\/db21-0193","article-title":"Coxsackievirus B vaccines prevent infection-accelerated diabetes in NOD mice and have no disease-inducing effect","volume":"70","author":"Stone","year":"2021","journal-title":"Diabetes."},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0011","doi-asserted-by":"crossref","first-page":"eaaz2433","DOI":"10.1126\/sciadv.aaz2433","article-title":"A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates","volume":"6","author":"Stone","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0012","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s12250-021-00444-1","article-title":"Development of a neonatal mouse model for Coxsackievirus B1 antiviral evaluation","volume":"36","author":"Yin","year":"2021","journal-title":"Virol Sin"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0013","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00253-018-09598-7","article-title":"Development of an efficient neutralization assay for Coxsackievirus A10","volume":"103","author":"Liu","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0014","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1021\/acsinfecdis.9b00333","article-title":"Rapid neutralization testing system for zika virus based on an enzyme-linked immunospot assay","volume":"6","author":"Li","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2020.113995","article-title":"Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2","volume":"287","author":"Park","year":"2021","journal-title":"J Virol Methods"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41426-017-0003-z","article-title":"Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population","volume":"7","author":"Zhu","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0017","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.chom.2021.01.001","article-title":"Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating","volume":"29","author":"Xu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0018","first-page":"433","article-title":"Enzyme and biotin labeling of antibody","volume":"32","author":"Wisdom","year":"1994","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0019","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/CVI.00359-13","article-title":"Development of an enzyme-linked immunosorbent spot assay to measure serum-neutralizing antibodies against coxsackievirus B3","volume":"21","author":"Yang","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ebiom.2018.12.051","article-title":"Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study","volume":"40","author":"Hershberger","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0021","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/s41591-021-01509-0","article-title":"Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial","volume":"27","author":"Stephenson","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0022","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(19)30036-4","article-title":"Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study","volume":"393","author":"Gaudinski","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0023","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/jmv.26096","article-title":"Seroprevalence of group B Coxsackieviruses: retrospective study in an Italian population","volume":"92","author":"Sciandra","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.diagmicrobio.2022.115676_bib0024","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3390\/microorganisms8091426","article-title":"Multiplexed high-throughput serological assay for human enteroviruses","volume":"8","author":"Saarinen","year":"2020","journal-title":"Microorganisms"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932200044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932200044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:57:34Z","timestamp":1760003854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288932200044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S073288932200044X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115676","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a rapid neutralization assay for the detection of neutralizing antibodies against coxsackievirus B1","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115676"}}